Gilder Gagnon Howe & Co’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.96M | Buy |
1,092,975
+265,618
| +32% | +$1.45M | 0.06% | 136 |
|
|
2025
Q1 | $4.57M | Buy |
827,357
+812,937
| +5,638% | +$4.49M | 0.06% | 137 |
|
|
2024
Q4 | $72.2K | Sell |
14,420
-20
| -0.1% | -$100 | ﹤0.01% | 253 |
|
|
2024
Q3 | $66.6K | Buy |
+14,440
| New | +$66.6K | ﹤0.01% | 249 |
|
|
2022
Q3 | – | Sell |
-172,864
| Closed | -$1.7M | – | 257 |
|
|
2022
Q2 | $1.7M | Sell |
172,864
-679,216
| -80% | -$6.69M | 0.03% | 181 |
|
|
2022
Q1 | $8.35M | Buy |
852,080
+145,847
| +21% | +$1.43M | 0.08% | 149 |
|
|
2021
Q4 | $6.98M | Sell |
706,233
-2,786
| -0.4% | -$27.5K | 0.04% | 197 |
|
|
2021
Q3 | $7.04M | Buy |
+709,019
| New | +$7.04M | 0.04% | 225 |
|